Related Experiment Videos
Clots and spots on ulcers: why and how to treat
1UCLA-CURE Digestive Disease Research Center, Bldg. 115, Room 318, VA Greater Los Angeles Healthcare System, 11301 Wilshire Boulevard, Los Angeles, CA 90073-1003, USA. djensen@mednet.ucla.edu
Insights
Urgent endoscopy guides treatment for severe upper GI bleeding. Endoscopic therapy is recommended for major hemorrhage stigmata, improving patient outcomes compared to medical treatment alone.
Area of Science:
- Gastroenterology
- Endoscopic procedures
- Gastrointestinal bleeding management
Background:
- Upper gastrointestinal (UGI) bleeding necessitates prompt diagnosis and treatment.
- Endoscopy plays a crucial role in identifying and managing UGI hemorrhage.
- Stigmata of ulcer hemorrhage guide therapeutic decisions.
Purpose of the Study:
- To outline the indications for urgent endoscopy in UGI bleeding.
- To define the role of endoscopic therapy based on stigmata of hemorrhage.
- To guide the level of care based on clinical presentation and endoscopic findings.
Main Methods:
- Review of clinical indications for urgent endoscopy.
- Classification of ulcer stigmata of hemorrhage (major vs. non-major).
- Analysis of outcomes from randomized trials comparing endoscopic and medical therapies.
Main Results:
- Major stigmata (active bleeding, visible vessels, clots) warrant endoscopic treatment.
- Endoscopic therapy improves outcomes for major stigmata compared to medical therapy alone.
- Non-major stigmata (flat spots, sloughs, clean bases) are managed with medical therapy.
Conclusions:
- Endoscopic therapy is indicated for major stigmata of hemorrhage in UGI bleeding.
- Repeat endoscopic treatment is recommended for rebleeding before considering surgery.
- Clinical and endoscopic factors determine patient disposition and level of care.
Abstract:
The clinical indication for urgent endoscopy with combined diagnosis and treatment is bleeding severe enough to warrant urgent medical attention. Stigmata of ulcer hemorrhage are utilized as a guide to endoscopic therapy. Active arterial bleeding, nonbleeding visible vessels, and adherent nonbleeding clots are always treated endoscopically. In randomized trials, patients with these "major stigmata" had better outcomes from endoscopic therapies than with medical therapies alone. Flat spots, gray or black sloughs, and clean ulcer bases are not treated endoscopically, since medical therapy alone affords good outcome. The current recommendation is to treat major stigmata of hemorrhage endoscopically for the initial bleeding episode and a second time for rebleeding before considering ulcer surgery. Clinical presentation and comorbidity and the endoscopic appearance of the ulcer (i.e., stigmata of hemorrhage) of patients with UGI bleeding are used to determine the subsequent level of care (e.g., discharge or ward or intensive care).